The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
Open accessAbstract
BACKGROUND: Recently, a cluster of patients was observed in France in whom primary pulmonary hypertension developed in patients exposed to derivatives of fenfluramine in appetite suppressants (anorexic agents), which are used for weight control. We investigated the potential role of anorexic agents and other suspected risk factors for primary pulmonary hypertension. METHODS: In a case-control study, we assessed 95 patients with primary pulmonary hypertension from 35 centers in France, Belgium, the United Kingdom, and the Netherlands and 355 controls recruited from general practices and matched to the patients' sex and age. RESULTS: The use of anorexic drugs (mainly derivatives of fenfluramine) was associated with an increased risk of primary pulmonary hypertension (odds ratio with any anorexic-drug use, 6.3; 95 percent confidence interval, 3.0 to 13.2). For the use of anorexic agents in the preceding year, the odds ratio was 10.1 (95 percent confidence interval, 3.4 to 29.9). When anorexic drugs were used to a total of more than three months, the odds ratio was 23.1 (95 percent confidence interval, 6.9 to 77.7). We also confirmed an association with several previously identified risk factors: a family history of pulmonary hypertension, infection with the human immunodeficiency virus, cirrhosis, and use of cocaine or intravenous drugs. CONCLUSIONS: The use of anorexic drugs was associated with the development of primary pulmonary hypertension. Active surveillance for this disease should be considered, particularly since their use is expected to increase in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Certainly, starvation, very-low-calorie diets, liquid protein diets, and obesity surgeries have been associated with prolongation of the QTc interval and increased risk of malignant dysrhythmias (1), and various pharmacologic agents have either limited efficacy or considerable toxicity (70 -72).”
From Obesity and Cardiovascular Disease (2009) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primary Pulmonary Hypertension
Rich, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., Detre, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,027
Self-citationThe Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,558
Self-citationTreatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
Rubin, L. J., Mendoza, J., Hood, M., McGoon, M., Barst, R., Williams, W. B., Diehl, J. H., Crow, J., & Long, W. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-485 · Cited by 701
Increased plasma serotonin in primary pulmonary hypertension
Hervé, P., Launay, J., Scrobohaci, M.-L., Brenot, F., Simonneau, G., PETITPRETZ, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. O. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 557
Self-citationHadengue, A., Benhayoun, M. K., Lebrec, D., & Benhamou, J. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90225-a · Cited by 497
Primary Pulmonary Hypertension and Cirrhosis: Are They Related?
McDonnell, P. J., Toye, P. A., & Hutchins, G. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.4.437 · Cited by 318
Primary Pulmonary Hypertension
Rubin, L. J. (1993) · CHEST Journal · doi:10.1378/chest.104.1.236 · Cited by 308
Primary pulmonary hypertension and fenfluramine use.
Brénot, F., Hervé, P., PETITPRETZ, P., Parent, F., Duroux, P., & Simonneau, G. (1993) · Heart · doi:10.1136/hrt.70.6.537 · Cited by 247
Self-citationPETITPRETZ, P., Brénot, F., Azarian, R., Parent, F., Rain, B., Hervé, P., & Simonneau, G. (1994) · Circulation · doi:10.1161/01.cir.89.6.2722 · Cited by 238
Self-citationPulmonary hypertension and fenfluramine
Douglas, J. G., Munro, J., KITCHIN, A. H., Muir, A. L., & Proudfoot, A. T. (1981) · BMJ · doi:10.1136/bmj.283.6296.881 · Cited by 180
Research works printed but not linked: 3
- Gurtner HP, 1985, Cor Vasa, 27, 160
- Michelakis ED, 1995, Am J Respir Crit Care Med, 151, A725
- Russel LA, 1992, Am Rev Respir Dis, 145, A717
Cited by
Sorted by citations
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,487
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,359
Obesity and Cardiovascular Disease
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.068 · Cited by 2,326
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,245
Pulmonary Arterial Hypertension in France
Humbert, M. J. C., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 1,994
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G. M., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,895
Self-citationPrimary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Pulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,467
Singh, J. P., Evans, J. C., Levy, D., Larson, M. G., Freed, L. A., Fuller, D. L., Lehman, B., & Benjamin, E. J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)01064-9 · Cited by 1,339
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S. M., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,183
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,128
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M., Rosenson, R. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192230 · Cited by 1,096
A global view of pulmonary hypertension
Hoeper, M. M., Humbert, M. J. C., Souza, R., Idrees, M. M., Kawut, S. M., Sliwa, K. S., Jing, Z., & Gibbs, J. S. R. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00543-3 · Cited by 1,086
Galiè, N., Torbicki, A., Barst, R. J., Dartevelle, P., Haworth, S. G., Higenbottam, T., Olschewski, H., Peacock, A. J., Pietra, G., Rubin, L. J., et al. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.09.014 · Cited by 1,049
Self-citationGuidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., de Leon, A. C., Edmunds, L. H., Fedderly, B. J., Freed, M. D., Gaasch, W. H., McKay, C. R., Nishimura, R. A., O’Gara, P. T., et al. (1998) · Circulation · doi:10.1161/01.cir.98.18.1949 · Cited by 1,026
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension
McGoon, M. D., Gutterman, D. D., Steen, V. D., Barst, R. J., McCrory, D. C., Fortin, T., & Loyd, J. E. (2004) · CHEST Journal · doi:10.1378/chest.126.1_suppl.14s · Cited by 929
Medical Therapy For Pulmonary Arterial Hypertension
Badesch, D. B., Abman, S. H., Ahearn, G. S., Barst, R. J., McCrory, D. C., Simonneau, G., & McLaughlin, V. V. (2004) · CHEST Journal · doi:10.1378/chest.126.1_suppl.35s · Cited by 829
Self-citationMechanisms of disease: pulmonary arterial hypertension
SCHERMULY, R. T., Ghofrani, H. A., Wilkins, M. R., & Grimminger, F. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.87 · Cited by 818
An epidemiological study of pulmonary arterial hypertension
Peacock, A., Murphy, N. F., McMurray, J. J. V., Caballero, L., & Stewart, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092306 · Cited by 793
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Padwal, R. S., & Majumdar, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60033-6 · Cited by 753
Thomson, J. R., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Humbert, M. J. C., Elliott, G. C., Ward, K., Yacoub, M. H., Mikhail, G., Rogers, P., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.741 · Cited by 730
Self-citationObesity and Cardiovascular Disease
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, X., & Eckel, R. H. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000216787.85457.f3 · Cited by 748
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schött, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 718
Atkinson, C., Stewart, S., Upton, P. D., Machado, R. D., Thomson, J. R., Trembath, R. C., & Morrell, N. W. (2002) · Circulation · doi:10.1161/01.cir.0000012754.72951.3d · Cited by 696
McQuillan, B., Picard, M. H., Leavitt, M. B., & Weyman, A. E. (2001) · Circulation · doi:10.1161/hc4801.100076 · Cited by 669
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 667
Putting chirality to work: the strategy of chiral switches
Agranat, I., Caner, H., & Caldwell, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd915 · Cited by 637
Rosenbaum, M. S., Leibel, R. L., & Hirsch, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370606 · Cited by 584
Eddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 577
Self-citationPrimary pulmonary hypertension
Gaine, S., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02111-4 · Cited by 554
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Machado, R. D., Pauciulo, M. W., Thomson, J. R., Lane, K. B., Morgan, N. V., Wheeler, L. A., Phillips, J. A., III, Newman, J. H., Williams, D., Galiè, N., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316947 · Cited by 535
Primary pulmonary hypertension
Runo, J. R., & Loyd, J. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13167-4 · Cited by 531
Pulmonary veno-occlusive disease
Montani, D., Lau, E., Dorfmüller, P., Girerd, B., Jaïs, X., Savale, L., Perros, F., Nossent, E. J., Garcia, G., Parent, F., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00026-2016 · Cited by 523
Self-citationEckel, R. H. (1997) · Circulation · doi:10.1161/01.cir.96.9.3248 · Cited by 512
Acute Oxygen-Sensing Mechanisms
Weir, Ε. K., López‐Barneo, J., Buckler, K. J., & Archer, S. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050002 · Cited by 489
Basic Science of Pulmonary Arterial Hypertension for Clinicians
Archer, S. L., Weir, Ε. K., & Wilkins, M. R. (2010) · Circulation · doi:10.1161/circulationaha.108.847707 · Cited by 483
Drugs That May Cause or Exacerbate Heart Failure
Page, R. L., II, O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. M. (2016) · Circulation · doi:10.1161/cir.0000000000000426 · Cited by 495
Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy, D. L. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.8 · Cited by 457
Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension
Velez‐Roa, S., Ciarka, A., Najem, B., Vachiéry, J., Naeije, R., & van de Borne, P. (2004) · Circulation · doi:10.1161/01.cir.0000140724.90898.d3 · Cited by 444
Review: The treatment and prevention of obesity: a systematic review of the literature
Glenny, A., O’Meara, S., Melville, A., Sheldon, T., & Wilson, C. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800495 · Cited by 434
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J., Hervé, P., Peoc’h, K., Tournois, C., Callebert, J., Nebigil, C. G., Étienne-Selloum, N., Drouet, L. O., Humbert, M. J. C., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
Self-citationYuan, J. X.-J., Aldinger, A. M., Juhaszova, M., Wang, J., Conte, J. V., Gaine, S., Orens, J. B., & Rubin, L. J. (1998) · Circulation · doi:10.1161/01.cir.98.14.1400 · Cited by 424
Thomsen, W. J., Grottick, A. J., Menzaghi, F., Saldana, H. R., Espitia, S. A., Yuskin, D., Whelan, K. T., Martin, M. W., Morgan, M. E., Chen, W., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133348 · Cited by 403
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Gräf, S., Haimel, M., Bleda, M., Hadinnapola, C., Southgate, L., Li, W., Hodgson, J., Liu, B., Salmon, R. M., Southwood, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03672-4 · Cited by 380
Critical Reviews in Therapeutic Drug Carrier Systems
Sachdeva, M. S., & Zucolotto, V. (2020) · Cited by 395
Sex differences and sex steroids in lung health and disease
Townsend, E. A., Miller, V. M., & Prakash, Y. S. (2012) · Endocrine Reviews · doi:10.1210/er.2010-0031 · Cited by 395
Lagae, L., Sullivan, J., Knupp, K., Laux, L., Polster, T., Nikanorova, M., Devinsky, O., Cross, J. H., Guerrini, R., Talwar, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32500-0 · Cited by 384
Long-term pharmacotherapy for obesity and overweight
Padwal, R. S., Rucker, D., Li, S. K., Curioni, C., & Lau, D. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004094.pub2 · Cited by 384
Rich, J. D., Shah, S. J., Swamy, R. S., Kamp, A. N., & Rich, S. (2010) · CHEST Journal · doi:10.1378/chest.10-1269 · Cited by 370
Self-citationProblems due to Small Samples and Sparse Data in Conditional Logistic Regression Analysis
Greenland, S., Schwartzbaum, J., & Finkle, W. D. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010240 · Cited by 367
Practice Guideline for the Treatment of Patients with Eating Disorders
Nakai, Y. (2016) · 心身医学 · Cited by 364
Pulmonary Veno-Occlusive Disease
Montani, D., Achouh, L., Dorfmüller, P., Pavec, J. L., Sztrymf, B., Tchérakian, C., Rabiller, A., Haque, R. A., Sitbon, O., Jaïs, X., et al. (2008) · Medicine · doi:10.1097/md.0b013e31818193bb · Cited by 356
Self-citationThe Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States
Frost, A., Badesch, D. B., Barst, R. J., Benza, R. L., Elliott, C. G., Farber, H. W., Krichman, A. M., Liou, T. G., Raskob, G. E., Wason, P., et al. (2010) · CHEST Journal · doi:10.1378/chest.10-0075 · Cited by 355
Primary Pulmonary Hypertension
Archer, S. L., & Rich, S. (2000) · Circulation · doi:10.1161/01.cir.102.22.2781 · Cited by 353
Self-citationAGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Grunvald, E., Shah, R., Hernaez, R., Chandar, A. K., Pickett-Blakely, O., Teigen, L. M., Harindhanavudhi, T., Sultan, S., Singh, S., & Davitkov, P. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.08.045 · Cited by 347
Rothberg, M. B., Celestin, C., Fiore, L. D., Lawler, E. V., & Cook, J. R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00005 · Cited by 335
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension
Bonderman, D., Jakowitsch, J., Adlbrecht, C., SCHEMPER, M., Kyrle, P. A., Schönauer, V., Exner, M., Klepetko, W., Kneußl, M., Maurer, G., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-10-0657 · Cited by 334
Current and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 327
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
Eddahibi, S., Hanoun, N., Lanfumey, L., Lesch, K., Raffestin, B., Hamon, M., & Adnot, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8678 · Cited by 330
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
Camp, G. V., Flamez, A., Cosyns, B., Weytjens, C., Muyldermans, L., Zandijcke, M. V., SUTTER, J. D., Santens, P., Decoodt, P., Moerman, C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15945-x · Cited by 320
Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension
Jeffery, T. K., & Morrell, N. W. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.130041 · Cited by 309
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Pulmonary Arterial Hypertension
Chin, K., & Rubin, L. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.024 · Cited by 317
Halford, J. C. G., Harrold, J. A., Boyland, E. J., Lawton, C. L., & Blundell, J. E. (2007) · Drugs · doi:10.2165/00003495-200767010-00004 · Cited by 308
Rubin, L. J. (2004) · CHEST Journal · doi:10.1378/chest.126.1_suppl.7s · Cited by 308
Setola, V., Hufeisen, S. J., Grande-Allen, K. J., Veselý, I., Glennon, R. A., Blough, B. E., Rothman, R. B., & Roth, B. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1223 · Cited by 305
Metabolic and weight-loss effects of a long-term dietary intervention in obese patients
Ditschuneit, H. H. M., Flechtner‐Mors, M., Johnson, T. D., & Adler, G. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.2.198 · Cited by 304
Pathobiology of Pulmonary Hypertension
Rabinovitch, M. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092033 · Cited by 300
Pulmonary Veno-occlusive Disease
Mandel, J., Mark, E. J., & Hales, C. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9912045 · Cited by 296
Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension
Eddahibi, S., Guignabert, C., Barlier‐Mur, A., Dewachter, L., Fadel, É., Dartevelle, P., Humbert, M. J. C., Simonneau, G., Hanoun, N., Saurini, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591321 · Cited by 296
Self-citationPulmonary veno-occlusive disease
Montani, D., Price, L., Dorfmüller, P., Achouh, L., Jaïs, X., Yaici, A., Sitbon, O., Musset, D., Simonneau, G., & Humbert, M. J. C. (2008) · European Respiratory Journal · doi:10.1183/09031936.00090608 · Cited by 296
Self-citationMultivariable Analysis: A Practical Guide for Clinicians and Public Health Researchers
Katz, M. H. (2011) · Cited by 298
Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension
Cool, C. D., Rai, P. R., Yeager, M. E., Hernández-Saavedra, D., Serls, A. E., Bull, T., Geraci, M. W., Brown, K. M., Routes, J. M., Tuder, R. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035115 · Cited by 292
Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32
Nichols, W. C., Koller, D. L., Slovis, B. S., Foroud, T., Terry, V. H., Arnold, N. D., Siemieniak, D. R., Wheeler, L. A., Phillips, J. A., Newman, J. H., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-277 · Cited by 281
Insulin resistance in pulmonary arterial hypertension
Zamanian, R. T., Hansmann, G., Snook, S., Lilienfeld, D. E., Rappaport, K., Reaven, G. M., Rabinovitch, M., & Doyle, R. L. (2008) · European Respiratory Journal · doi:10.1183/09031936.00000508 · Cited by 269
Rudarakanchana, N. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1517 · Cited by 270
Yi, E. S., Kim, H., Ahn, H.-K., Strother, J., Morris, T. A., Masliah, E., Hansen, L. A., PARK, K., & Friedman, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912131 · Cited by 267
Pathogenic mechanisms of pulmonary arterial hypertension
Chan, S. Y., & Loscalzo, J. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.09.006 · Cited by 269
A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve Regurgitation
Jick, H., Vasilakis‐Scaramozza, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., & Derby, L. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391102 · Cited by 263
Grünig, E., Janssen, B. J., Mereles, D., Barth, U., Borst, M. M., Vogt, I. R., Fischer, C., Olschewski, H., Kuecherer, H. F., & Kübler, W. (2000) · Circulation · doi:10.1161/01.cir.102.10.1145 · Cited by 255
Nabbout, R., Mistry, A., Zuberi, S., Villeneuve, N., Gil-Nagel, A., Sanchez-Carpintero, R., Stephani, U., Laux, L., Wirrell, E., Knupp, K., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4113 · Cited by 251
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B. R., Lamm, D. L., O’Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 255
Ho, P. M., Peterson, P. N., & Masoudi, F. A. (2008) · Circulation · doi:10.1161/circulationaha.107.721357 · Cited by 251
Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension
Hampl, V., & Herget, J. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1337 · Cited by 245
Losing Weight — An Ill-Fated New Year's Resolution
Kassirer, J. P., & Angell, M. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801013380109 · Cited by 253
Chaouat, A. (2004) · Thorax · doi:10.1136/thx.2003.11890 · Cited by 248
Genetic basis of pulmonary arterial hypertension
Newman, J. H., Trembath, R. C., Morse, J. A., Grünig, E., Loyd, J. E., Adnot, S., Coccolo, F., Ventura, C., Phillips, J. A., Knowles, J. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.028 · Cited by 246
Pharmacotherapies for Obesity: Past, Current, and Future Therapies
Ioannides‐Demos, L. L., Piccenna, L. G., & McNeil, J. J. (2010) · Journal of Obesity · doi:10.1155/2011/179674 · Cited by 241
Murphy, D. L., Fox, M. A., Timpano, K. R., Moya, P. R., Ren‐Patterson, R. F., Andrews, A. M., Holmes, A., Lesch, K., & Wendland, J. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.034 · Cited by 237
Eddahibi, S., Chaouat, A., Morrell, N. W., Fadel, É., Fuhrman, C., Bugnet, A.-S., Dartevelle, P., HOUSSET, B., Hamon, M., Weitzenblum, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091409.53101.e8 · Cited by 232
MacLean, M. R., Hervé, P., Eddahibi, S., & Adnot, S. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703570 · Cited by 231
KANEKO, F. T., ARROLIGA, A. C., DWEIK, R. A., COMHAIR, S. A., LASKOWSKI, D., OPPEDISANO, R., THOMASSEN, M. J., & ERZURUM, S. C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9802066 · Cited by 228
Contribution of the 5-HT 1B Receptor to Hypoxia-Induced Pulmonary Hypertension
Keegan, A., Morecroft, I., Smillie, D., Hicks, M. N., & MacLean, M. R. (2001) · Circulation Research · doi:10.1161/hh2401.100426 · Cited by 224
Grünig, E., Weissmann, S., Ehlken, N., Fijałkowska, A., Fischer, C., Fourme, T., Galiè, N., Ghofrani, H. A., Harrison, R. E., Huez, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.800938 · Cited by 219
Self-citationInduction of Serotonin Transporter by Hypoxia in Pulmonary Vascular Smooth Muscle Cells
Eddahibi, S., Fabre, V., Boni, C., Martres, M., Raffestin, B., Hamon, M., & Adnot, S. (1999) · Circulation Research · doi:10.1161/01.res.84.3.329 · Cited by 213
Aminorex, Fenfluramine, and Chlorphentermine Are Serotonin Transporter Substrates
Rothman, R. B., AYESTAS, M. A., Dersch, C. M., & Baumann, M. H. (1999) · Circulation · doi:10.1161/01.cir.100.8.869 · Cited by 213
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
Humbert, M. J. C., Deng, Z., Simonneau, G., Barst, R. J., Sitbon, O., Wolf, M., Cuervo, N., Moore, K. J., Hodge, S. E., Knowles, J. A., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.01762002 · Cited by 211
Self-citation
Metadata
- Authors
- Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., Simonneau, G., & Bégaud, B.
- Affiliations
- Jewish General Hospital (CA)
- Hôpital Antoine-Béclère (FR)
- University of Illinois Chicago (US)
- Centre Hospitalier Universitaire de Liège (BE)
- University of Sheffield (GB)
- Hammersmith Hospital (GB)
- Maastricht University Medical Centre (NL)
- Hôpital Bichat-Claude-Bernard (FR)
- Hôpital Pellegrin (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-08-29
- Volume
- 335
- Issue
- 9
- Pages
- 609-616
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2329065056
- Cited by
- 1,162
- References
- 26
- Citations by year
- 2026: 7 · 2025: 23 · 2024: 22 · 2023: 21 · 2022: 22 · 2021: 16 · 2020: 16 · 2019: 20 · 2018: 27 · 2017: 29 · 2016: 18 · 2015: 30 · 2014: 27 · 2013: 39 · 2012: 34
- FWCI
- 71.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- idiopathic pulmonary arterial hypertension, appetite suppressants, drug-induced pulmonary hypertension, risk factors, HIV infection, liver cirrhosis, cocaine use, intravenous drug use, weight management
- MeSH terms
- Adolescent, Adult, Aged, Appetite Depressants, Belgium, Female, Fenfluramine, France, United Kingdom, Heart Function Tests, Hemodynamics, Humans, Hypertension, Pulmonary, Male, Middle Aged, Netherlands, Prospective Studies, Respiratory Function Tests, Risk Factors, Incidence, Logistic Models, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
